(Q36724219)

15 August 2017

1 reference

title

Inosine pranobex in the treatment of HIV infection: a review (English)

1 reference

15 August 2017

Inosine pranobex in the treatment of HIV infection: A review (English)

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

9 November 2022

author name string

C. De Simone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726683

9 November 2022

G. Famularo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726683

9 November 2022

S. Tzantzoglou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726683

9 November 2022

S. Moretti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726683

9 November 2022

E. Jirillo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726683

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1726683

9 November 2022

publication date

1 January 1991

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:019205619190120V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

https://api.elsevier.com/content/article/PII:019205619190120V?httpAccept=text/plain

9 November 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

International Journal of Immunopharmacology

9 November 2022

published in

1 reference

15 August 2017

13 Suppl 1

1 reference

15 August 2017

19-27

1 reference

Effect of isoprinosine on in vitro proliferative responses of human lymphocytes stimulated by antigen

15 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS

9 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Effects of isoprinosine in animal models of depressed T-cell function

9 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

9 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Effects of ribavirin on red blood cells.

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Influence of methisoprinol (isoprinosine) on HIV-infected human lymphocytes: in vitro immunological, virological, and ultrastructural studies

9 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Inosine pranobex and zidovudine metabolism

9 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

The selectivity of isoprinosine, NPT 15392, avridine and cyclophosphamide on multiple immune responses in rats

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Inosiplex treatment of acquired immunodeficiencies: a clinical model for effective immunomodulation

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes

9 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Effect of Isoprinosine Against Influenza and Some Other Viruses Causing Respiratory Diseases

9 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases

9 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections

9 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group

9 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms

9 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobex

9 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

The Walter Reed staging classification for HTLV-III/LAV infection.

9 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Suppressor cell activity after isoprinosine treatment of lymphocytes from normal mice

9 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Isoprinosine as an Immunopotentiator

9 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Modulation of human T lymphocyte functions by isoprinosine

9 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Combinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1

9 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

An in vitro study on the effects of isoprinosine on immune responses in cancer patients

9 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Isoprinosine-induced modulation of T-helper-cell subsets and antigen-presenting monocytes (Leu M3 + Ia +) resulted in improvement of T- and B-lymphocyte functions, in vitro in ARC and AIDS patients

9 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients

9 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

9 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy

9 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production

9 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

Inosiplex, a stimulating agent for normal human T cells and human leukocytes

9 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0192-0561(91)90120-V

9 November 2022

Identifiers

1 reference

release_ec5chtkmdjbp7ac4em6najnbve

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ec5chtkmdjbp7ac4em6najnbve

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference